Sangye Menla Pharmaceuticals Private Limited

Manufactures pharmaceuticals with registered office in Bhubaneswar, Orissa.

2020 | Khorda, Odisha (India) | Active
Last Updated:

Sangye Menla Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.00 M
  • Company Age 4 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth %
  • Profit Growth -398.55%
  • Ebitda -398.55%
  • Net Worth -1.45%
  • Total Assets -0.04%

About Sangye Menla Pharmaceuticals

Sangye Menla Pharmaceuticals Private Limited (SMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 December 2020 (Four years and two months 26 days old ). Its registered office is in Khorda, Odisha, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.

Parthiv Mehta, Dharitri Patnaik, and Manoranjan Rout serve as directors at the Company.

Company Details

  • Location

    Khorda, Odisha, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24296OR2020PTC035040

  • Company No.

    035040

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    09 Dec 2020

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Cuttack

Industry

Pharma

Who are the key members and board of directors at Sangye Menla Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Parthiv Mehta Country flag representing In Director 09-Dec-2020Current
Dharitri Patnaik Country flag representing In Director 09-Dec-2020Current
Manoranjan Rout Country flag representing In Director 09-Dec-2020Current

Financial Performance of Sangye Menla Pharmaceuticals.

Sangye Menla Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 398.55% decrease in profit. The company's net worth dipped by a decrease of 1.45%.

Sangye Menla Pharmaceuticals revenue growth over time
Sangye Menla Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-0.04%
Profit or Loss
-398.55%
Net Worth
-1.45%
EBITDA
-398.55%

What is the Ownership and Shareholding Structure of Sangye Menla Pharmaceuticals?

Unlock access to Sangye Menla Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Sangye Menla Pharmaceuticals?

Sangye Menla Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Sangye Menla Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sangye Menla Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sangye Menla Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sangye Menla Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Sangye Menla Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Sangye Menla Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack.

  • Director Appointment

    Parthiv Surendra Mehta was appointed as a Director was appointed as a Director on 09 Dec 2020 & has been associated with this company since 4 years 2 months .

  • Director Appointment

    Dharitri Patnaik was appointed as a Director was appointed as a Director on 09 Dec 2020 & has been associated with this company since 4 years 2 months .

  • Director Appointment

    Manoranjan Rout was appointed as a Director was appointed as a Director on 09 Dec 2020 & has been associated with this company since 4 years 2 months .

  • Company Incorporation

    Sangye Menla Pharmaceuticals Private Limited was registered on 09 Dec 2020 with Roc Cuttack & aged 4 years 2 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Sangye Menla Pharmaceuticals Private Limited?

    Sangye Menla Pharmaceuticals Private Limited was incorporated on 09 Dec 2020.

  • What is authorized share capital and paid-up capital of Sangye Menla Pharmaceuticals Private Limited?

    The authorized share capital of Sangye Menla Pharmaceuticals Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.00 M.

  • Who are the current board members & directors of Sangye Menla Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Sangye Menla Pharmaceuticals Private Limited.

    • Parthiv Surendra Mehta
    • Dharitri Patnaik
    • Manoranjan Rout

  • What is the registered address of Sangye Menla Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Sangye Menla Pharmaceuticals Private Limited is Plot No.Ga-62 Gayatri Vihar, Patia India, Bhubaneswar, Orissa, 751024.

  • What is the corporate identification number (CIN) and company number of Sangye Menla Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Sangye Menla Pharmaceuticals Private Limited is U24296OR2020PTC035040 and the company number is 035040 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Sangye Menla Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Sangye Menla Pharmaceuticals Private Limited has experienced an downturn of -1.45%.

  • When was the last Balance Sheet of Sangye Menla Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Sangye Menla Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.